Nonetheless, it’s crucial to note that immunomodulators commonly used in IBD management, such as corticosteroids, aminosalicylates, methotrexate, anti-TNF-α, and other biologics, could increase the risk of opportunistic infections in the oral cavity65. Here, TNF is linked to inflammatory bowel disease.